Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–7 of 7 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: fenoldopam Clear all

Conditions: Kidney Failures, Acute
Interventions: Intra-Renal Fenoldopam, Furosemide; Drug
Lead sponsor: Southeast Renal Research Institute; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Chattanooga, Tennessee

Conditions: Partial Nephrectomy
Interventions: Fenoldopam, Placebo; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2010
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hypertension
Interventions: fenoldopam, Placebo; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 70 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Patent Ductus Arteriosus (PDA), Acute Kidney Injury (AKI)
Interventions: Fenoldopam, 0.9%NS; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 0 Days to 28 Days
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Salt-sensitive Hypertension
Interventions: Fenoldopam; Drug
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Acute Renal Failure
Interventions: Fenoldopam Mesylate and/or MESNA; Drug
Lead sponsor: Southeast Renal Research Institute; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Chattanooga, Tennessee

Conditions: Cardiac Surgery With Cardiopulmonary Bypass
Interventions: Fenoldopam; Drug
Lead sponsor: Summa Health System; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Akron, Ohio

Search by objective public record fields.

Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury

The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery

Effect of Gene Variants on Dopamine Receptor Natriuretic Responses

Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants

Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet

Vasodilators and Anti-Oxidant Therapy in Early ATN

A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery